Work

Pilot trial of ibrutinib plus nivolumab in patients with metastatic renal cell cancer (mRCC): results from a dose-finding cohort.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.4580

Authors: Primo Lara, Mamta Parikh, Daniel Robles, Frances Lara, Frederick J. Meyers, Chong-xian Pan

Institutions: University of California, Davis, UC Davis Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4247641963

Cites:

Cited by:

Related to: 10